Global DNA Sequencing Product Share, Size, Growth Trends And Forecast 2017-2022

Global DNA Sequencing Products Market to Reach US$ 9 Billion

Copyright © IMARC. All Rights Reserved

About IMARC Group

Report Description

IMARC is a leading advisor on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations.

Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Report Description and Highlights Report Description Global DNA Sequencing Products Market to Reach US$ 9 Billion The global DNA sequencing products market has been witnessing a positive growth. This can be attributed to the confluence of declining prices of sequencing and increasing development in sequencing technologies.

The latest report by IMARC Group, titled “DNA Sequencing Products Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022�, finds that the global DNA sequencing products market reached a value of more than US$ 3 Billion in 2016. Over the past few decades, DNA sequencing has become an important part of biology and other sciences. It ascertains the physical order of four bases of DNA which include adenine, guanine, thymine, and cytosine. Apart from this, DNA sequencing is also used for measuring the sequence of individual genes, entire genomes and full chromosomes of any organism. Some advantages offered by DNA sequencing include high accuracy and speed, low cost and precise results from low sample input.

Request Sample of the Report http://www.imarcgroup.com/request?type=report&id=839&flag=B

Report Description and Highlights

Report Description and Highlights

Report Description

Highlights of the global DNA sequencing products market: • •

•

Advancements in technology act as a major factor bolstering the growth of the market.

Research organisations represent the largest application area accounting for the majority of the global share.

North America is the leading market for DNA sequencing products.

In recent years, a number of manufacturers across the globe have invested in several R&D projects due to which there have been technological developments in personalised medicines. For instance, an international scientific research project, namely, the Human Genome Project brought about a major transformation in DNA sequencing technologies. Medical facilities are now offering sequencing-based treatments, quantitative assessments of genomic sequences and rapid DNA sequencer for large-scale and Sanger sequencing. This, in turn, has positively contributed to the growth of the global DNA sequencing products market. As a result, global DNA sequencing products market is further expected to reach a value of more than US$ 9 Billion, exhibiting a CAGR of more than 19% during 2017-2022. .

Read full report @ http://www.imarcgroup.com/dna-sequencing-products-market

Report Description and Highlights

Report Description

On the basis of product type, consumables and reagents currently exhibit a clear dominance in the market, followed by equipment. Based on application, research organisations represent the largest application area of DNA sequencing products market. It is followed by hospitals, pharmaceutical and life science companies. Region-wise, North America accounts for the majority of the total global share. This is due to declining costs of sequencing along with the presence of well-established vendors in the region. Other major markets include Europe, Asia-Pacific, Latin America and Middle East and Africa. The competitive landscape of the market has also been analysed with some of the key players operating in the market being Illumina Inc., Thermo Fisher Scientific Inc., Roche Diagnostics, Pacific Biosciences of California, Inc. and Beckman Coulter.

The report by IMARC Group has examined the global DNA sequencing products market on the basis Product Type: • •

Consumables and Reagents Equipment

Application: • •

Research Organisations Hospitals, Pharmaceutical and Life Science Companies

Report Description and Highlights Report Description Region: • • • • •

North America Europe Asia Pacific Latin America Middle East and Africa

Key Players: • • • • •

Illumina Inc. Thermo Fisher Scientific Inc. Roche Diagnostics Pacific Biosciences of California, Inc. Beckman Coulter

Browse More Related Report : http://www.imarcgroup.com/categories/healthcare-marketresearch-reports

Report Description and Highlights

Report Description

Š 2017 IMARC All Rights Reserved

This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).

Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing.

International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.

IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

Contact Us

FOR MORE DETAILS Visit us at :

http://www.imarcgroup.com Stay With Us:

TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com